BioNexus Gene Lab Corp. (BGLC) NASDAQ
2.28
-0.02(-0.87%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.28
-0.02(-0.87%)
Currency In USD
| Market Cap | 7.33M |
| Enterprise Value | 5.13M |
| P/E Ratio | -1.9 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 0.86 |
| Price/Book Ratio | 0.68 |
| Enterprise/Revenue | 0.16 |
| Enterprise/EBITDA | -0.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.55 |
| Operating Margin | -0.55 |
| Return On Assets | -0.14 |
| Return On Equity | -0.37 |
| Revenue | 7.42M |
| Revenue/Share | 2.2 |
| Gross Profit | 1.09M |
| EBITDA | -2.8M |
| Net Income | -2.98M |
| Diluted EPS | -1.61 |
| Total Cash | 3.96M |
| Total Cash/Share | 1.64 |
| Total Debt | 216,428 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 6.52 |
| Book Value Per Share | 3.35 |
| 52-Week Change | -30.49 |
| 52-Week High | 15.6 |
| 52-Week Low | 1.92 |
| Moving Average 50 Days | 2.19 |
| Moving Average 200 Days | 3.68 |
| Average Volume | 13,103 |
| Shares Outstanding | 2.01M |
| % Held by Institutions | 0.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | April 07, 2025 |